Cargando…

Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma

Glycine N-methyltransferase (GNMT) expression is vastly downregulated in hepatocellular carcinomas (HCC). High rates of GNMT knockout mice developed HCC, while overexpression of GNMT prevented aflatoxin-induced carcinogenicity and inhibited liver cancer cell proliferation. Therefore, in this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kant, Rajni, Yen, Chia-Hung, Lu, Chung-Kuang, Lin, Ying-Chi, Li, Jih-Heng, Chen, Yi-Ming Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881495/
https://www.ncbi.nlm.nih.gov/pubmed/27153064
http://dx.doi.org/10.3390/ijms17050669
_version_ 1782433970707759104
author Kant, Rajni
Yen, Chia-Hung
Lu, Chung-Kuang
Lin, Ying-Chi
Li, Jih-Heng
Chen, Yi-Ming Arthur
author_facet Kant, Rajni
Yen, Chia-Hung
Lu, Chung-Kuang
Lin, Ying-Chi
Li, Jih-Heng
Chen, Yi-Ming Arthur
author_sort Kant, Rajni
collection PubMed
description Glycine N-methyltransferase (GNMT) expression is vastly downregulated in hepatocellular carcinomas (HCC). High rates of GNMT knockout mice developed HCC, while overexpression of GNMT prevented aflatoxin-induced carcinogenicity and inhibited liver cancer cell proliferation. Therefore, in this study, we aimed for the identification of a GNMT inducer for HCC therapy. We established a GNMT promoter-driven luciferase reporter assay as a drug screening platform. Screening of 324 pure compounds and 480 crude extracts from Chinese medicinal herbs resulted in the identification of Paeonia lactiflora Pall (PL) extract and the active component 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranoside (PGG) as a GNMT inducer. Purified PL extract and PGG induced GNMT mRNA and protein expression in Huh7 human hepatoma cells and in xenograft tumors. PGG and PL extract had potent anti-HCC effects both in vitro and in vivo. Furthermore, PGG treatment induced apoptosis in Huh7 cells. Moreover, PGG treatment sensitized Huh7 cells to sorafenib treatment. Therefore, these results indicated that identifying a GNMT enhancer using the GNMT promoter-based assay might be a useful approach to find drugs for HCC. These data also suggested that PGG has therapeutic potential for the treatment of HCC.
format Online
Article
Text
id pubmed-4881495
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48814952016-05-27 Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma Kant, Rajni Yen, Chia-Hung Lu, Chung-Kuang Lin, Ying-Chi Li, Jih-Heng Chen, Yi-Ming Arthur Int J Mol Sci Article Glycine N-methyltransferase (GNMT) expression is vastly downregulated in hepatocellular carcinomas (HCC). High rates of GNMT knockout mice developed HCC, while overexpression of GNMT prevented aflatoxin-induced carcinogenicity and inhibited liver cancer cell proliferation. Therefore, in this study, we aimed for the identification of a GNMT inducer for HCC therapy. We established a GNMT promoter-driven luciferase reporter assay as a drug screening platform. Screening of 324 pure compounds and 480 crude extracts from Chinese medicinal herbs resulted in the identification of Paeonia lactiflora Pall (PL) extract and the active component 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranoside (PGG) as a GNMT inducer. Purified PL extract and PGG induced GNMT mRNA and protein expression in Huh7 human hepatoma cells and in xenograft tumors. PGG and PL extract had potent anti-HCC effects both in vitro and in vivo. Furthermore, PGG treatment induced apoptosis in Huh7 cells. Moreover, PGG treatment sensitized Huh7 cells to sorafenib treatment. Therefore, these results indicated that identifying a GNMT enhancer using the GNMT promoter-based assay might be a useful approach to find drugs for HCC. These data also suggested that PGG has therapeutic potential for the treatment of HCC. MDPI 2016-05-04 /pmc/articles/PMC4881495/ /pubmed/27153064 http://dx.doi.org/10.3390/ijms17050669 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kant, Rajni
Yen, Chia-Hung
Lu, Chung-Kuang
Lin, Ying-Chi
Li, Jih-Heng
Chen, Yi-Ming Arthur
Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
title Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
title_full Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
title_fullStr Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
title_full_unstemmed Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
title_short Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
title_sort identification of 1,2,3,4,6-penta-o-galloyl-β-d-glucopyranoside as a glycine n-methyltransferase enhancer by high-throughput screening of natural products inhibits hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881495/
https://www.ncbi.nlm.nih.gov/pubmed/27153064
http://dx.doi.org/10.3390/ijms17050669
work_keys_str_mv AT kantrajni identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma
AT yenchiahung identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma
AT luchungkuang identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma
AT linyingchi identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma
AT lijihheng identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma
AT chenyimingarthur identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma